Subsequent Events

3 Months Ended

Mar. 31, 2014

Subsequent Events [Abstract]

Subsequent Events

Note 6. Subsequent Events

  On April 1, 2014, the Company issued 5,338,809 shares of common stock to Norwood Immunology Ltd (NIL) as per agreement and thereby eliminated the remaining contingent consideration liability.

  On April 3, 2014, the Board of directors approved the liquidation of Mymetics Luxembourg the end of June 2014, as this entity had no operating activities since its incorporation in November 2001. The liquidation of Mymetics Luxembourg will not have a material impact on the Company's continuing financial position, results of operations, or cash flows.